Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Br J Clin Pharmacol. 2007 Nov;64(5):566-74. Epub 2007 Aug 31.

    Thioridazine: resurrection as an antimicrobial agent?

    Source

    Royal Infirmary of Edinburgh, Edinburgh, UK. ruben.thanacoody@luht.scot.nhs.uk

    Abstract

    The emergence of multiresistant bacterial strains and the continuing burden of infectious disease globally point to the urgent need for novel affordable antimicrobial drugs. Thioridazine is a phenothiazine antipsychotic drug with well-recognized antimicrobial activity, but this property has not been harnessed for clinical use as a result of its central nervous system and cardiac side-effects. The cardiotoxicity of thioridazine has recently been shown to be structurally specific at a molecular level, whereas its antimicrobial properties are shared by a number of phenothiazine analogues. This raises the possibility that its enantiomers or its inactive metabolite, the ring sulphoxide, may act as a lead compound in the future development of antimicrobial drugs to face the new challenges in infectious disease.

    Comment in

    • Old drugs--new uses. [Br J Clin Pharmacol. 2007]
    PMID:
    17764469
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2203271
    Free PMC Article

    Images from this publication.See all images (1)Free text

    Figure 1

      Supplemental Content

      Icon for Blackwell Publishing Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk